The
recent judgement by India?s Controller
of Patents granting Compulsory License
to an Indian pharmaceutical company for
the production of a cancer drug, the patent
for which is held by German pharmaceuticals
and chemicals giant Bayer, is not just
historic but path breaking.
*
This article was originally published
in Frontline, Volume 29 - Issue 08: Apr.
21-May 04, 2012.
April
27, 2012. |
|
|
|
This Document is in Adobe
Acrobat format and would
need a PDF reader to
view it. |
|
|
View/
Download the
full text in PDF format |
|
if
you have problem
opening the file, right click
on hyperlink and select "SaveTarget
as" to save
the file on your hard drive. |
|
|
|
|
|
Click below
to get Adobe
Acrobat Reader, a free software
to view and print Adobe Portable
Document Format (PDF) files. |
|
|
|
|
|
|
|